| (-)-epigallocatechin 3-gallate | decreases methylation | ISO | RGD:733729 | 6480464 | epigallocatechin gallate results in decreased methylation of MLH1 promoter | CTD | PMID:14633667 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:733729 | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of MLH1 mRNA | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | increases expression | ISO | RGD:733729 | 6480464 | epigallocatechin gallate results in increased expression of MLH1 mRNA; more ... | CTD | PMID:14633667 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:733730 | 6480464 | Tetrachlorodibenzodioxin affects the expression of MLH1 mRNA | CTD | PMID:20702594 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MLH1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:733730 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of MLH1 mRNA | CTD | PMID:19465110 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of MLH1 mRNA | CTD | PMID:21346803 |
| 4-hydroxynon-2-enal | decreases expression | ISO | RGD:733729 | 6480464 | 4-hydroxy-2-nonenal results in decreased expression of MLH1 mRNA | CTD | PMID:12419474 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:733729 | 6480464 | [decitabine co-treated with trichostatin A] affects the methylation of MLH1 promoter | CTD | PMID:18069755 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 mRNA | CTD | PMID:21875463 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 protein | CTD | PMID:21875463 PMID:19259094 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 mRNA | CTD | PMID:19032668 more ... |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:733729 | 6480464 | decitabine results in decreased methylation of MLH1 promoter | CTD | PMID:19080631 PMID:19032668 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:733729 | 6480464 | PXD101 promotes the reaction [decitabine results in increased expression of MLH1 protein]; more ... | CTD | PMID:19259094 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 protein | CTD | PMID:19259094 PMID:21875463 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:733729 | 6480464 | decitabine results in decreased methylation of MLH1 | CTD | PMID:21875463 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 mRNA | CTD | PMID:19032668 more ... |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:733729 | 6480464 | decitabine results in increased expression of MLH1 | CTD | PMID:19080631 |
| 5-aza-2'-deoxycytidine | affects methylation | ISO | RGD:733729 | 6480464 | decitabine affects the methylation of MLH1 promoter | CTD | PMID:18069755 |
| 5-aza-2'-deoxycytidine | decreases methylation | ISO | RGD:733729 | 6480464 | decitabine results in decreased methylation of MLH1 promoter | CTD | PMID:19032668 PMID:19080631 |
| 5-fluoro-2'-deoxyuridine | multiple interactions | ISO | RGD:733729 | 6480464 | AZD 2281 inhibits the reaction [MLH1 protein results in decreased susceptibility to Floxuridine] | CTD | PMID:22194930 |
| 5-fluoro-2'-deoxyuridine | decreases response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein results in decreased susceptibility to Floxuridine | CTD | PMID:22194930 |
| 5-fluorouracil | affects response to substance | ISO | RGD:733729 | 6480464 | MLH1 mRNA affects the susceptibility to Fluorouracil | CTD | PMID:18497967 |
| 5-fluorouracil | affects response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein affects the susceptibility to Fluorouracil | CTD | PMID:18949393 |
| 5-fluorouracil | increases response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein results in increased susceptibility to Fluorouracil | CTD | PMID:17914563 |
| bisphenol A | increases expression | ISO | RGD:733729 | 6480464 | bisphenol A results in increased expression of MLH1 mRNA | CTD | PMID:22121209 |
| carmustine | affects response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein affects the susceptibility to Carmustine | CTD | PMID:18430789 |
| chromium(6+) | decreases expression | ISO | RGD:733729 | 6480464 | chromium hexavalent ion results in decreased expression of MLH1 mRNA | CTD | PMID:19376149 |
| chromium(6+) | multiple interactions | ISO | RGD:733729 | 6480464 | MLH1 protein results in increased susceptibility to [chromium hexavalent ion co-treated with Ascorbic Acid] | CTD | PMID:17169990 |
| chromium(6+) | increases response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein results in increased susceptibility to chromium hexavalent ion | CTD | PMID:17301063 |
| chromium(6+) | multiple interactions | ISO | RGD:733729 | 6480464 | MLH1 protein promotes the reaction [Ascorbic Acid results in increased susceptibility to chromium hexavalent ion] | CTD | PMID:17301063 |
| cisplatin | affects localization | ISO | RGD:733729 | 6480464 | Cisplatin affects the localization of MLH1 protein | CTD | PMID:21064154 |
| copper(2+) sulfate | decreases expression | ISO | RGD:733729 | 6480464 | Copper Sulfate results in decreased expression of MLH1 mRNA | CTD | PMID:19549813 |
| coumestrol | multiple interactions | ISO | RGD:733729 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of MLH1 mRNA | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:733729 | 6480464 | Coumestrol results in increased expression of MLH1 mRNA | CTD | PMID:19167446 |
| cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of MLH1 mRNA | CTD | PMID:11906922 |
| cyclosporin A | increases expression | ISO | RGD:733729 | 6480464 | Cyclosporine results in increased expression of MLH1 mRNA | CTD | PMID:20106945 |
| cypermethrin | increases expression | ISO | RGD:733730 | 6480464 | cypermethrin results in increased expression of MLH1 mRNA | CTD | PMID:21142847 |
| diazoxide | increases expression | ISO | RGD:733730 | 6480464 | Isoproterenol results in increased expression of MLH1 mRNA | CTD | PMID:21335049 |
| dibutyl phthalate | decreases expression | ISO | RGD:733730 | 6480464 | Dibutyl Phthalate results in decreased expression of MLH1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | ISO | RGD:733730 | 6480464 | Dibutyl Phthalate results in decreased expression of MLH1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of MLH1 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:733729 | 6480464 | Diethylstilbestrol results in increased expression of MLH1 mRNA | CTD | PMID:15766595 |
| diethylstilbestrol | affects response to substance | ISO | RGD:733730 | 6480464 | MLH1 gene mutant form affects the susceptibility to Diethylstilbestrol | CTD | PMID:15700306 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MLH1 mRNA | CTD | PMID:18775883 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of MLH1 mRNA | CTD | PMID:17264098 PMID:18775883 |
| fenofibrate | increases expression | EXP | | 6480464 | Fenofibrate results in increased expression of MLH1 mRNA | CTD | PMID:18775883 |
| fenofibrate | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of MLH1 mRNA | CTD | PMID:18253720 |
| gefitinib | decreases expression | ISO | RGD:733729 | 6480464 | gefitinib results in decreased expression of MLH1 mRNA | CTD | PMID:16685379 |
| imiquimod | decreases expression | ISO | RGD:733730 | 6480464 | imiquimod results in decreased expression of MLH1 mRNA | CTD | PMID:21878529 |
| isoprenaline | increases expression | ISO | RGD:733730 | 6480464 | Isoproterenol results in increased expression of MLH1 mRNA | CTD | PMID:21335049 |
| L-ascorbic acid | multiple interactions | ISO | RGD:733729 | 6480464 | MLH1 protein results in increased susceptibility to [chromium hexavalent ion co-treated with Ascorbic Acid] | CTD | PMID:17169990 |
| L-ascorbic acid | multiple interactions | ISO | RGD:733729 | 6480464 | MLH1 protein promotes the reaction [Ascorbic Acid results in increased susceptibility to chromium hexavalent ion] | CTD | PMID:17301063 |
| lycopene | increases expression | ISO | RGD:733729 | 6480464 | lycopene results in increased expression of MLH1 mRNA | CTD | PMID:16886892 |
| myo-inositol hexakisphosphate | multiple interactions | ISO | RGD:733730 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of MLH1] | CTD | PMID:21154115 |
| myo-inositol hexakisphosphate | affects methylation | ISO | RGD:733730 | 6480464 | Phytic Acid affects the methylation of MLH1 promoter | CTD | PMID:21154115 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:733730 | 6480464 | Ethylnitrosourea results in increased expression of MLH1 | CTD | PMID:21154115 |
| N-ethyl-N-nitrosourea | multiple interactions | ISO | RGD:733730 | 6480464 | Phytic Acid inhibits the reaction [Ethylnitrosourea results in increased expression of MLH1] | CTD | PMID:21154115 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | RGD:733729 | 6480464 | Methylnitronitrosoguanidine results in decreased expression of MLH1 protein | CTD | PMID:17671175 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:733729 | 6480464 | Methylnitrosourea promotes the reaction [MSH2 protein binds to MLH1 protein binds to PMS2 protein] | CTD | PMID:16204460 |
| N-methyl-N-nitrosurea | affects response to substance | ISO | RGD:733730 | 6480464 | MLH1 protein affects the susceptibility to Methylnitrosourea | CTD | PMID:12967659 |
| N-methyl-N-nitrosurea | multiple interactions | ISO | RGD:733730 | 6480464 | MLH1 affects the reaction [MGMT protein affects the reaction [Methylnitrosourea results in increased activity of CASP3 protein]]; more ... | CTD | PMID:13679151 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in decreased expression of MLH1 mRNA | CTD | PMID:18253720 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Fenofibrate co-treated with Diethylnitrosamine] results in increased expression of MLH1 mRNA | CTD | PMID:18775883 |
| paracetamol | affects expression | ISO | RGD:733730 | 6480464 | Acetaminophen affects the expression of MLH1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:733729 | 6480464 | Acetaminophen results in increased expression of MLH1 mRNA | CTD | PMID:22230336 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MLH1 mRNA | CTD | PMID:20127075 PMID:19162173 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of MLH1 mRNA | CTD | PMID:19162173 PMID:20127075 |
| quinoline | increases expression | ISO | RGD:733729 | 6480464 | quinoline analog results in increased expression of MLH1 mRNA | CTD | PMID:19417133 |
| sodium dichromate | increases expression | ISO | RGD:733730 | 6480464 | sodium bichromate results in increased expression of MLH1 mRNA | CTD | PMID:22155349 |
| sterigmatocystin | multiple interactions | ISO | RGD:733729 | 6480464 | MLH1 protein affects the reaction [Sterigmatocystin results in increased expression of CDK1 protein]; more ... | CTD | PMID:23296099 |
| sterigmatocystin | affects response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein affects the susceptibility to Sterigmatocystin | CTD | PMID:23296099 |
| sterigmatocystin | increases expression | ISO | RGD:733729 | 6480464 | Sterigmatocystin results in increased expression of MLH1 protein; more ... | CTD | PMID:23296099 |
| temozolomide | affects response to substance | ISO | RGD:733730 | 6480464 | MLH1 protein affects the susceptibility to temozolomide | CTD | PMID:12967659 |
| temozolomide | affects response to substance | ISO | RGD:733729 | 6480464 | MLH1 protein affects the susceptibility to temozolomide | CTD | PMID:18430789 |
| temozolomide | multiple interactions | ISO | RGD:733729 | 6480464 | [temozolomide co-treated with O(6)-benzylguanine] affects the expression of MLH1 protein | CTD | PMID:20980775 |
| tert-butyl hydroperoxide | decreases expression | ISO | RGD:733729 | 6480464 | tert-Butylhydroperoxide results in decreased expression of MLH1 mRNA | CTD | PMID:12419474 |
| trichostatin A | multiple interactions | ISO | RGD:733729 | 6480464 | [decitabine co-treated with trichostatin A] affects the methylation of MLH1 promoter | CTD | PMID:18069755 |